---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-123682"
form_type: "8-K"
ticker: "CGC"
cik: "0001737927"
company_name: "Canopy Growth Corp"
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:54:24.462926+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Canopy Growth Q2 revenue down 9% to $63M; adjusted EBITDA loss improves 54% to $5.5M

## Summary
- Net revenue $63.0M, down 9% YoY; excluding divested businesses, up 3%.
- Adjusted EBITDA loss $5.5M, improved 54% YoY; net loss from cont. ops $131.6M.
- Canada medical revenue +16% YoY; Storz & Bickel +32% on Germany reform and US sales.
- Early prepayment reduced secured term loan by US$100M; cash balance $231M.
- Canopy USA closed Wana acquisition post-quarter; Acreage acquisition on track for H1 2025.

## SEC filing metadata
- accession: 0000950170-24-123682
- form_type: 8-K
- ticker: CGC
- cik: 0001737927
- company_name: Canopy Growth Corp
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737927/000095017024123682/0000950170-24-123682-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737927/000095017024123682/cgc-20241108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-123682
- JSON: https://secwatch.observer/filing/0000950170-24-123682.json
- Plain text: https://secwatch.observer/filing/0000950170-24-123682.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.